Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | GGH | Q92820 | 1/20 | 0.32 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.31 |
| ▸ | CTH | P32929 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glyphosate SCHEMBL7624303 | 0.98 | MEN1 (0.37) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL726233 | 0.98 | MEN1 (0.37) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL9245368 | 0.96 | MEN1 (0.36) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL118893 | 0.91 | LMNA (0.42) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL18578 | 0.91 | LMNA (0.42) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL118894 | 0.91 | LMNA (0.42) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL303742 | 0.91 | GGPS1 (0.31) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL27974141 | 0.89 | MEN1 (0.37) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL7999922 | 0.89 | LMNA (0.40) | MEN1LMNAHPGDTSHRBLM | |
| Glyphosate SCHEMBL3294890 | 0.89 | LMNA (0.40) | MEN1LMNAHPGDTSHRBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101460533-B | Reverse phase microcapsules for active ingredients, simplified preparation method thereof and combination formulations WDG-CS, ZC, EC-SC and CX | GAT MICROENCAPSULATION AG | 2013-10-23 | — | — | CN | disclosed |
| US-8337900-B2 | Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulation WDG-CS, ZC, EC-SC, and CX | FMC CORPORATION | 2012-12-25 | — | — | US | disclosed |
| CN-101460533-A | Reverse phase microcapsules for active ingredients, simplified preparation method thereof and combination formulations WDG-CS, ZC, EC-SC and CX | GAT MICROENCAPSULATION AG (AT) | 2009-06-17 | — | — | CN | disclosed |
| US-20090053271-A1 | Reverse-Phase Microcapsules for Actice Ingredients, Simplified Process of Manufacture Thereof and Combined Formulation Wdg- Cs,Zc, Ec-Sc, and Cx | FMC CORPORATION | 2009-02-26 | — | — | US | disclosed |
| EP-2004718-A1 | REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX | GAT Microencapsulation AG (AT) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007112933-A1 | REVERSE-PHASE MICROCAPSULES FOR ACTIVE INGREDIENTS, SIMPLIFIED PROCESS OF MANUFACTURE THEREOF AND COMBINED FORMULATIONS WDG-CS, ZC, EC-SC AND CX | GAT MICROENCAPSULATION AG (AT) | 2007-10-11 | — | — | WO | disclosed |